期刊文献+

CD133^+卵巢癌干细胞通过CXCL16/CXCR6维持其侵袭迁移能力 被引量:4

CD133^+ ovarian cancer stem cells maintain high abilities of invasion and migration via CXCL16 / CXCR6 axis
下载PDF
导出
摘要 目的探讨人卵巢癌干细胞(ovarian cancer stem cells,OCSCs)自分泌趋化因子CXCL16对OCSCs增殖及侵袭迁移能力的影响。方法采用Real-time PCR、ELISA及流式细胞仪检测A2780细胞株诱导的CD133+OCSCs和CD133-非卵巢癌干细胞(non ovarian cancer stem cells,n OCSCs)中CXCL16及CXCR6的表达;用CCK-8法检测阻断CXCL16对OCSCs增殖能力的影响;利用Transwell迁移、侵袭实验检测分别阻断CXCL16或CXCR6及shRNA沉默CXCL16对OCSCs侵袭迁移能力的影响。结果与n OCSCs比较,OCSCs中CXCL16及CXCR6 mRNA均表达上调(P<0.01)。ELISA结果显示OCSCs的CXCL16分泌量远远高于n OCSCs[(2 434.00±204.65)vs(129.33±31.64)ng/m L,P<0.01]。流式细胞仪检测发现OCSCs表面CXCR6表达率显著高于n OCSCs(60.6%vs 2.4%,P<0.01)。与对照组比较,中和抗体阻断CXCL16对OCSCs增殖无明显影响(P>0.05),然而阻断CXCL16或CXCR6能明显抑制OCSCs的侵袭迁移能力(P<0.01)。shRNA沉默CXCL16同样能显著抑制OCSCs的侵袭迁移能力(P<0.01)。结论 CD133+卵巢癌干细胞自分泌CXCL16,后者与CXCR6结合可维持卵巢癌干细胞高侵袭迁移能力。 Objective To determine the effect of CXCL16 /CXCR6 axis on the proliferation,invasion and migration of ovarian cancer stem cells( OCSCs). Methods CD133^+OCSCs were isolated from ovarian cancer cell line A2780 by serum-free culture selection. The difference of CXCL16 and CXCR6 expression between CD133^+OCSCs and CD133^-non-ovarian cancer stem cells( n OCSCs) was detected by real-time PCR,enzyme linked immunosorbent assay and flow cytometry. CCK-8 assay was used to assess the effect of CXCL16 on proliferation of OCSCs. Transwell migration assay and Matrigel invasion assay were used to determine invasion and migration ability of OCSCs after blocking CXCL16 or CXCR6 with neutralizing antibody or short hairpin RNA( shRNA). Results Compared with n OCSCs,CXCL16 and CXCR6 at mRNA expression level were increased in OCSCs( P〈0. 01). OCSCs had more CXCL16 secretion( 2 434. 00 ±204. 65 ng / mL) than n OCSCs( 129. 33 ± 31. 64 ng / mL)( P〈0. 01). And the CXCR6 expression in OCSCs( 60. 6%) was higher than that in n OCSCs( 2. 4%)( P〈0. 01). CCK-8 assay showed that the proliferation of OCSCs was not affected after blocking CXCL16 with neutralizing antibody( P〉0. 05). When CXCL16 or CXCR6 was blocked with neutralizing antibody,OCSCs showed decrease of invasion and migration ability( P〈0. 01). Invasion and migration ability of OCSCs was also significantly inhibited when blocking CXCL16 with shRNA( P〈0. 01). Conclusion Autocrine chemokine CXCL16 can bind to CXCR6 to maintain high ability of invasion and migration of CD133^+OCSCs.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2015年第8期757-761,共5页 Journal of Third Military Medical University
关键词 卵巢肿瘤 肿瘤干细胞 趋化因子受体CXCL16 趋化因子受体CXCR6 肿瘤侵袭 细胞迁移 ovarian neoplasms neoplastic stem cells chemokine CXCL16 chemokine receptor CXCR6 neoplasm invasiveness cell migration
  • 相关文献

参考文献19

  • 1Charafe-Jauffret E, Ginestier C, Iovino F, et al. Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer[ J]. Clin Cancer Res, 2010, 16(1) : 45 -55.
  • 2Levina V, Marrangoni A, Wang T, et al. Elimination of hu- man lung cancer stem cells through targeting of the stem cell factor-c-kit autocrine signaling loop [ J]. Cancer Res, 2010, 70(1) : 338 -346.
  • 3Pang R, Law W L, Chu A C, et al. A subpopulation of CD26^+ cancer stem cells with metastatic capacity in human colorectal cancer[J]. Cell Stern Cell, 2010, 6(6) : 603 - 615.
  • 4Kryczek I, Liu S, Roh M, et al. Expression of aldehyde de- hydrogenase and CD133 defines ovarian cancer stem cells[J]. Int J Cancer, 2012, 130(1) : 29 -39.
  • 5Silva I A, Bai S, McLean K, et al. Aldehyde dehydrogenase in combination with CD133 defines angiogenie ovarian cancer stem cells that portend poor patient survival[ J]. Cancer Res, 2011, 71(11) : 3991 -4001.
  • 6Baba T, Convery P A, Matsumura N, et al. Epigenetie regu- lation of CD133 and tumorigenicity of CDl33^+ ovarian cancer cells[J]. Oncogene, 2009, 28(2): 209-218.
  • 7Ping Y F, Yao X H, Jiang J Y, et al. The chemokine CX- CL12 and its receptor CXCR4 promote glioma stem cell-medi- ated VEGF production and tumor angiogenesis via PI3K/AKT signaling[ J ]. J Pathol, 2011,224 (3) : 344 - 354.
  • 8Ginestier C, Liu S, Diebel M E, et al. CXCR1 blockade se- lectively targets human breast cancer stem cells in vitro and in xenografts[J]. J Clin Invest, 2010, 120(2) : 485 -497.
  • 9Faber A, Hoermann K, Stern-Straeter J, et al. Functional effects of SDF-1α, on a CIM4( + ) CXCR4( + ) squamous cell carcinoma cell line as a model for interactions in the cancer stem cell niche [J]. Oncol Rep, 2013, 29 (2): 579 - 584.
  • 10王峰,曹蕾,庞丽娜,周然,王留兴.CXCR4通过EMT促进食管癌侵袭转移过程[J].第三军医大学学报,2013,35(22):2443-2447. 被引量:2

二级参考文献28

  • 1朱言亮,陈龙邦,王靖华,褚晓源,陈一天,张群,夏欣一.肺腺癌细胞株SPC-A1中侧群细胞的分离与肿瘤干细胞样特征的鉴定[J].中国肺癌杂志,2008,11(5):681-685. 被引量:6
  • 2Zhao R C, Zhu Y S, Shi Y. New hope for cancer treatment: exploring the distinction between normal adult stem cells and cancer stem cells [J]. Pharmacol Ther, 2008, 119(1) : 74 -82.
  • 3Bonnet D, Dick J E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell [ J ]. Nat Med, 1997, 3(7) : 730 -737.
  • 4Bapat S A, Mali A M, Koppikar C B, et al. Stem and progenitor - like cells contribute to the aggressive behavior of human epithelial ovarian cancer[ J]. Cancer Res, 2005, 65 (8) :3025 - 3029.
  • 5Oda I, Yamada M, Yoshinaga S, el ttl. [.ymph-node metastasis in sur- gical resection of intramucosal esophageal adenocarcinoma [ J ]. Dig En- dosc, 2013, 25 ( Supp! 2 ) : 177 - 180.
  • 6Gros S J, Graeff H, I)renckhan A, et al. CXCR4/SDF-lc(-mediated chemotaxis in an in it,o model of metastatic esophageal carcinoma[ J ]. In Vivo, 2012, 26(4): 711 -718.
  • 7Muller A, Sonkoly E, Eulert C, et al. Chemokine receptors in head and neck cancer: association with metastatic spread and regulation dur- ing chemotherapy[ J]. Int J Cancer, 2006, 118(9) : 2147 -2157.
  • 8Albert S, HuuL-seau M, ttalimi C, et al. Prognostic value of the che- mokine receptor CXCR4 and epithelial-to-mesenehymaI transition in patients with squamous cell eareinoma of the mobile tongue[ J]. Oral Oneol, 2012, 48(12) : 1263 - 1271.
  • 9BergersG,BenjaminLE.Tumorigenesisandtheangiogenicswitch[J].NatRevCancer,2003,3(6):401-410.
  • 10CarmelietP,JainRK.Angiogenesisincancerandotherdiseases[J].Nature,2000,407(6801):249-257.

共引文献9

同被引文献100

  • 1吴月明.G-蛋白耦联受体、组织蛋白酶-D和CD133在结肠腺癌中的表达及相关性[J].中国老年学杂志,2014,34(9):2370-2372. 被引量:1
  • 2曾宪起,申长虹,浦佩玉,杨树源.应用替莫唑胺对照司莫司丁治疗恶性脑胶质瘤的疗效观察[J].中华神经外科杂志,2006,22(4):204-207. 被引量:50
  • 3王文举,李鸿钧,孙茂盛.NF-κB与持久炎症及肿瘤发生关系[J].生命的化学,2007,27(3):197-199. 被引量:16
  • 4Groves MD, Puduvalli VK, Gilbert MR, et al. Two phase II trials of temozolomide with interferon-alpha2b (pegylated and non-pegylated) in patients with recurrent glioblastoma multiforme. Br J Cancer. 2009; 101 (4):615-620.
  • 5Wang JD, He B, Dai WB, et al. Targeting glioblastoma cancer stem cell marker CD133 by heptapeptide-modified DSPE-PEG micelles. Journal of Chinese Pharmaceutical Sciences. 2015;24(1 ):34-39.
  • 6Colman H, Berkey BA, Maor MH, et al. Phase II Radiation Therapy Oncology Group trial of conventional radiation therapy followed by treatment with recombinant interferon-beta for supratentorial glioblastoma: results of RTOG 9710. Int J Radiat Oncol Biol Phys. 2006;66(3): 818-824.
  • 7Bai A, Li H, Huang Y, et al. A survey of overall life satisfaction and its association with breast diseases in Chinese women[j]. Cancer Med, 2016, 5(1):111-119.
  • 8Hurvitz SA, Pietras RJ. Rational management of endocrine resistance in breast cancer: a comprehensive review of estrogen receptor biology, treatment options, and future directions[J]. Cancer, 2008, 113(9):2385-2397.
  • 9Briest S, Stearns V. Tamoxifen metabolism and its effect on endocrine treatment of breast cancer[J]. Clin Adv Hematol Oncol, 2009, 7(3): 185-192.
  • 10Lonning PE. Adjuvant endocrine treatment of early breast cancer[J]. Hematol Oncol Clin North Am, 2007, 21(2):223-238.

引证文献4

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部